J Crit Care 2013, 28:317.11. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155:529?36. 12. A quality assessment tool for diagnostic accuracy studies: QUADAS-2: Background document. via http://www.bris.ac.uk/quadas/quadas-2/. accessed 5 June 2013. 13. Hasegawa H: Estimation of coagulation-fibrinolytic factors in DIC. Bibl Haematol 1983, 49:173?80. 14. Clayton DG, Miro AM, Kramer DJ, Rodman N, Wearden S: Quantification of thrombelastographic changes after blood component transfusion in patients with liver disease in the PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/12027669 intensive care unit. Anesth Analg 1995, 81:272?78. 15. Mohri M, Suzuki M, Sugimoto E, Sata M, Yamamoto S, Maruyama I: Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma. Thromb Haemost 1998, 80:925?29. 16. Baldwin I, Tan HK, Bridge N, Bellomo R: A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration. Ren Fail 2000, 22:297?06. 17. Doria C, Mandala L, Smith JD, Caruana G, Scott VL, Gruttadauria S, Magnone M, Marino IR: Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004, 18:365?71. 18. Dunser MW, Fries (E)-1,2-Di(pyridin-4-yl)ethene DR, Schobersberger W, Ulmer H, Wenzel V, Friesenecker B, Hasibeder WR, Mayr AJ: Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9871638 syndrome? Anesth Analg 2004, 99:201?06. 19. King DR, Cohn SM, Feinstein AJ, Proctor KG: 5-difluoroaniline rel-((1R Systemic coagulation changes caused by pulmonary artery catheters: laboratory findings and clinical correlation. J Trauma 2005, 59:853?57. 20. Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006, 10:R24. 21. Nilsson CU, Hellkvist PD, Engstrom M: Effects of recombinant human activated protein C on the coagulation system: a study with rotational thromboelastometry. Acta Anaesthesiol Scand 2008, 52:1246?249. 22. Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA: Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma 2009, 66:1509?515. 23. Mineo G, Cascio ND, Canzio D, Marino L, Evangelico G, Cortegiani A, Raineri SM: Fondaparinux vs low molecular weight heparin as a thromboprophylaxis in critically ill patients: coagulation status monitored by thromboelastography [abstract]. Intensive Care Med 2009, Conference:S217. 24. Sharma P, Saxena R: A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state. Am J Clin Pathol 2010, 134:97?02. 25. White H, Zollinger C, Jones M, Bird R: Can thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol 2010, 32:167?73. 26. Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K: Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinol.